Clinical trial · Interventional
A Supportive Care Intervention for Older Caregivers of Older Adults with Advanced Cancer
Development and Feasibility of a Supportive Care Intervention for Older Caregivers of Older Adults with Advanced Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Study has been closed to accrual earlier than anticipated and will not resume.
Summary
Brief summary (as posted)
This project assesses the feasibility of utilizing the geriatric assessment as a tool to identify distressed older caregivers of older adults with cancer. The investigator will engage key stakeholders including older caregivers of older adults with cancer, experts in geriatric oncology and primary care physicians to develop and pilot a supportive care intervention to improve outcomes in older caregivers.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Experimental (Delphi Surveys) | Other | — | UNRESOLVED |
| Experimental (Focus Groups) | Other | — | UNRESOLVED |
| Qualitative interviews | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Experimental
- description
- Participants will receive a geriatric assessment which consists of validated questionnaires that are used to assess health status of older adults with cancer. Based on participant responses, tailored recommendations will be provided.
- interventionNames
- Other: Experimental (Delphi Surveys)
- Other: Experimental (Focus Groups)
- Other: Qualitative interviews
Primary outcomes (3)
- measure
- Percentage of participants who enroll and complete the GA
- timeFrame
- 8 weeks per participant
- description
- Percentage of participants who were approached, enrolled in the study and completed the GA will be determined.
- measure
- Time for caregivers to complete the GA
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 65 Years
Show eligibility criteria text
Patient Inclusion Criteria * Patient and caregiver be aged 65 or older * Patient with a diagnosis of solid tumor malignancy or lymphoma, any stage * Patients who have initiated a new line of treatment (surgery, radiation therapy, chemotherapy, immunotherapy, or targeted therapy) OR are being considered for new line of treatment (surgery, radiation therapy, chemotherapy, immunotherapy, or targeted therapy). * Patients and caregivers must be able to provide informed consent, or if it is determined that they do not have decision-making capacity, a patient-designated health care proxy must sign consent per institutional University of Rochester and Research Subject Review Board policies on consent for incapacitated/decisionally impaired subjects. Patient Exclusion Criteria * Patient or caregiver is less than 65 years of age * Patient and caregivers who do not have decision-making capacity (decisionally or cognitively impaired) AND do NOT have a previously designated health care proxy available to sign consent. Caregiver Inclusion Criteria * Caregivers enrolled in phase I * Patient and caregiver have completed a GA Caregiver Exclusion Criteria • Patient and caregiver have not completed a GA Stakeholder Inclusion Criteria * Member of SCOREboard Community Advisory Board * Aged 65 years or older * Has been a family member, partner, friend or caregiver to an older adult with cancer Stakeholder Exclusion Criteria • None Geriatric Oncology Expert Inclusion Criteria * Members of the Cancer and Aging Research Group * Primary care physicians who care for older adults Geriatric Oncology Expert Exclusion Criteria • None
References
Publications (0)
Data not yet available